Stock Track | 4DMedical Soars 12.26% Intraday on TGA Approval for CT:VQ Lung Imaging Software

Stock Track
Jun 29

4DMedical Ltd's stock surged 12.26% during intraday trading on Monday, following the announcement of a significant regulatory milestone for the company.

The sharp increase came after 4DMedical secured approval from Australia's Therapeutic Goods Administration (TGA) for its CT:VQ lung imaging software. This clearance enables the commercial rollout of the technology nationwide through inclusion on the Australian Register of Therapeutic Goods (ARTG).

CT:VQ represents an innovative approach that generates ventilation-perfusion imaging from routine non-contrast chest CT scans. This technology eliminates the reliance on radiotracers or nuclear medicine infrastructure, potentially offering a more accessible and efficient diagnostic solution for lung conditions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10